Mysterious Link: How Chickenpox Might Complicate Bacterial Infections
"Unraveling the connection between varicella-zoster virus and severe lymph node infections, and what it means for your health."
Non-tuberculous mycobacteria (NTM) are common microorganisms found in the environment. While generally harmless, they can sometimes cause infections, especially in individuals with compromised immune systems. These infections often manifest as skin, soft tissue, or lung diseases, but can also affect the lymph nodes.
Lymphadenitis, or inflammation of the lymph nodes, due to NTM is rare in people with healthy immune systems. Typically, the body's defenses are well-equipped to handle these bacteria, preventing them from causing serious harm. However, when the immune system is weakened, NTM can take hold, leading to more severe infections.
A recent case study sheds light on a peculiar situation: a young girl with a common chickenpox infection developed a severe lymph node infection caused by Mycobacterium fortuitum. This raises questions about how viral infections like chickenpox can disrupt the immune system and increase susceptibility to bacterial complications.
The Burden of NTM Lymphadenitis in Children
Non-tuberculous mycobacterial (NTM) lymphadenitis is a significant cause of pediatric head-and-neck infections, with Mycobacterium avium complex accounting for approximately 80% of reported cases. A 28-year multicenter cohort study from Spain (1996–2023) found that NTM lymphadenitis case numbers remained stable during an initial prospective phase from 2013 to 2020, but a sharp decline was observed during 2021–2022. Disease onset occurred during spring or June in 45.9% of cases in that cohort. The geographical distribution and frequency of mycobacterial species involved in pediatric lymphadenitis varies by region, though M. avium-intracellulare complex remains the dominant causative agent worldwide.
Diagnostic and Treatment Challenges
Diagnosing NTM lymphadenitis remains challenging because clinical presentation alone cannot reliably distinguish it from tuberculous lymphadenitis or other causes of cervical adenitis. Standard approaches involve fine-needle aspiration or excisional biopsy followed by culture and species identification, though these methods can be time-consuming and may yield false negatives. Treatment typically involves surgical excision or antibiotic regimens, but there is no universally accepted consensus on optimal therapy, leading to variability in clinical management across institutions. The slow growth rate of many NTM species further complicates timely diagnosis and initiation of appropriate treatment.
Evolving Understanding of Atypical Mycobacteria
Non-tuberculous mycobacteria were historically referred to as 'atypical mycobacteria' before the terminology shifted to NTM. The recognition that NTM, rather than Mycobacterium tuberculosis, account for most cases of mycobacterial lymphadenitis in children in many regions represented an important milestone in infectious disease understanding. Advances in molecular diagnostics and species-level identification over recent decades have transformed our ability to differentiate NTM species, revealing a far more complex taxonomic landscape than previously appreciated. This evolving taxonomy has implications for both clinical management and epidemiological surveillance.
The Case: Chickenpox Opens the Door to Bacterial Infection
A previously healthy nine-year-old girl developed palpable lymphadenomegaly in her left cervical region, accompanied by fever, but without any other systemic manifestations. The patient also showed typical varicella symptoms, and was prescribed to rest for 15 days. During her chickenpox infection, the node continued to grow, and eventually developed into a vesicle. After this period, a vesicle with purulent content was observed on her lower left gum, it was associated with a dental fracture that had occurred prior to the emergence of the node. Concerns arose when a vesicle with purulent content appeared near a previously fractured tooth. Initial treatments with amoxicillin and cephalexin, common antibiotics, proved ineffective.
- Persistent Lesion: A circular lesion was discovered during a physical examination, measuring 4.5cm in diameter with well limited, prominent, hardened, and erythematosus edges; a granular base covered with purulent content; and a surrounding purple area.
- Biopsy Results: Another biopsy was performed, revealing areas of necrotizing granulomatosis without evidence of infectious agents. Two palpable lymph nodes were identified at the mandible that were static, of hardened consistency, and painful to touch. The largest node measured 1.5cm in diameter. No other lymph node chain was observed.
- Culture Analysis: The cervical nodule was cultured for common germs, AARB, fungi, Actinomyces, and Nocardia. Part of the material was sown in culture media (lamb blood agar, MacConkey agar, Sabouraud agar, Mycosel agar, Lowenstein-Jensen medium, and Ogawa-Kudoh agar).
Advancing Knowledge in NTM Infections
Recent research continues to refine our understanding of NTM lymphadenitis epidemiology and management. The 28-year Spanish multicenter study represents one of the most comprehensive longitudinal analyses of NTM lymphadenitis, providing insights into seasonal patterns and temporal trends in disease incidence. Researchers are increasingly recognizing the importance of species-level identification, as different NTM species may require different treatment approaches. The interplay between host immune status and NTM disease manifestation remains an active area of investigation, particularly in understanding why certain populations are disproportionately affected.
Diagnostic Pitfalls and Misidentification Risks
A significant challenge in NTM lymphadenitis management is the risk of species misidentification, as illustrated by documented cases of Mycobacterium fortuitum being incorrectly identified in clinical samples. M. fortuitum is an infrequent human pathogen that causes opportunistic infections primarily in immunocompromised patients or those with chronic illness, though infections in immunocompetent individuals have been reported. NTM lymphadenitis accounts for approximately 95% of head-and-neck mycobacterial lymphadenitis cases, typically presenting as a painless, slowly progressive, unilateral mass. A study of 138 cases of NTM lymphadenitis in children aimed to identify risk factors for complicated disease, highlighting that not all cases follow a straightforward clinical course.
NTM Versus Tuberculous Lymphadenitis
Differentiating NTM lymphadenitis from tuberculous lymphadenitis is critical because treatment approaches differ substantially. A review of 19 children with NTM lymphadenitis emphasized that most cases of mycobacterial lymphadenitis in children are caused by non-tuberculous rather than tuberculous mycobacteria. Atypical mycobacteria are a common cause of granulomatous lymphadenitis in immunocompetent children aged 1 to 5 years and immunocompromised adults. Importantly, Streptococcus and Corynebacterium are themselves capable of causing lymphadenitis and are susceptible to first-line TB treatment, meaning such treatment may alleviate pathology in tuberculosis lymphadenitis partly by killing taxa other than Mycobacterium.
Why Chickenpox Can Lead to Bacterial Complications
The case raises a critical question: how did chickenpox, a common childhood illness, pave the way for a severe bacterial infection? The answer lies in the virus's impact on the immune system. Varicella-zoster virus (VZV) interferes with the activation of phagocytes, the immune cells responsible for engulfing and destroying bacteria.
Bridging Chickenpox and Bacterial Complications
The intersection of viral infections like chickenpox and subsequent bacterial complications, including NTM lymphadenitis, underscores the importance of understanding post-infectious immune modulation. Varicella-zoster virus infection can compromise skin barrier integrity and transiently alter immune function, potentially creating windows of vulnerability to opportunistic pathogens including NTM. Clinicians managing chickenpox patients should remain vigilant for secondary bacterial infections that may present weeks after the initial viral illness. A multidisciplinary approach combining infectious disease expertise with immunological assessment may be warranted in complicated post-varicella cases.
Expanding Taxonomy and Treatment Markets
The taxonomic landscape of the Mycobacterium fortuitum complex is remarkably complex, with the 'Fortuitum-Vaccae' clade encompassing over 100 species as of recent classification efforts. The nontuberculous mycobacterium treatment market was estimated at USD 450.75 million in 2024 and is projected to reach USD 780.34 million by 2032, growing at a CAGR of 7.1% from 2025 to 2032. Advances in antibacterial agents for M. fortuitum are particularly noteworthy, as this emerging human pathogen has shown increasing prevalence and antibacterial resistance over the past two decades. Continued development of new drugs targeting rapidly growing NTM species will be essential to address the growing clinical challenge these organisms present.
Implications for Public Health Infrastructure
The relationship between common childhood viral infections and secondary bacterial complications highlights broader challenges in public health surveillance and clinical preparedness. Accurate diagnosis of post-infectious bacterial lymphadenitis requires access to specialized microbiological services that may not be available in all healthcare settings. The geographical variability in NTM species distribution suggests that regional epidemiological data should inform local treatment guidelines. As global travel increases and immunocompromised populations grow, the clinical burden of opportunistic infections including NTM is likely to evolve in ways that demand adaptive public health responses.
Patient Experience and Clinical Decision-Making
For families navigating a child's diagnosis of NTM lymphadenitis following chickenpox, the journey involves uncertainty about diagnosis, treatment duration, and potential scarring. The typically slow progression of NTM lymphadenitis means patients and clinicians must often decide between watchful waiting and intervention, a process that can be stressful and anxiety-provoking. Surgical excision, while often curative, carries risks of cosmetic deformity and nerve damage depending on lesion location. Antibiotic regimens, though less invasive, require prolonged courses that test patient and family compliance. These real-world considerations remind us that behind every statistic is a patient and family seeking answers and effective care.
VZV disrupts a key signaling pathway involving STAT3 and STAT1, transcription activators crucial for producing immune-boosting substances like interleukin (IL)-12) and reactive oxygen species (ERO). By dampening these responses, VZV weakens the macrophages' ability to eliminate bacteria effectively.
This case underscores the importance of considering NTM infections in patients presenting with lymphadenitis, especially when a recent viral infection like chickenpox has occurred. While NTM rarely causes disease in healthy individuals, viral infections can temporarily weaken the immune system, creating an opportunity for these bacteria to take hold and cause serious complications. Further research is needed to fully understand the interplay between viral infections and bacterial susceptibility.